BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 26, 2009
View Archived Issues
Array BioPharma discovers oncolytic checkpoint kinase inhibitors
Read More
Case control analysis reveals reduced AD risk with IV immunoglobulin
Read More
Enhanced fibrinolytic potency seen with reprogrammed streptokinases
Read More
Riluzole modulates alcohol self-administration and withdrawal in preclinical studies
Read More
Liraglutide safe and effective in combination with metformin and rosiglitazone
Read More
Astellas Pharma reports first quarter FY2009 results
Read More
Rifaximin accepted for filing and granted priority review by FDA
Read More
BrainStorm receives funding for ALS research trials
Read More
Nanotherapeutics awarded NIAID contract to develop inhaled smallpox antiviral
Read More
PharmaGap reports NCI results from GAP-107-B-8 testing
Read More
Regado enrolls first patient in phase I trial of anticoagulant REG1 System
Read More
R-Tech Ueno completes enrollment in phase II UF-021 study
Read More
Phase III Urocidin trial cleared to continue by DMC
Read More
Loramyc marketing authorization granted in Switzerland
Read More
Wyeth to continue liver X receptor target program initiated by Karo Bio
Read More
T-type calcium channel antagonist TTA-A8 a clinical candidate for sleep disorders
Read More
Preclinical characteristics of antidiabetic candidate canagliflozin described
Read More
GSK presents preclinical data on novel S1P1 agonist, PPI-4955, at recent ACS meeting
Read More
Shire designs prodrugs of mu opioid receptor ligands for pain treatment
Read More
Monoamine neurotransmitter reuptake inhibitors described by NeuroSearch
Read More
Bayer Schering Pharma identifies novel compounds acting on Toll-like receptors
Read More
Wisconsin Alumni Research Foundation describes VDR ligands for skin conditions
Read More
Bayer Schering Pharma claims novel MR antagonists, PR and AR agonists
Read More
Enrollment in phase IIa trial of ALV-003 for celiac disease started
Read More
Gene-based medicine for refractory angina enters phase I/IIa clinical development
Read More